Clinical trial
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any…
NCT00404989 · Syneos Health, Other · Recruiting
Key facts
| NCT number | NCT00404989 |
|---|---|
| Title | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. |
| Official title | Antiretroviral Pregnancy Registry |
| Acronym | APR |
| Lead sponsor | Syneos Health, Other |
| Collaborators | AbbVie Industry Alvogen Inc. Amneal Pharmaceuticals, LLC Apotex Corp. Boehringer Ingelheim Bristol-Myers Squibb Cipla Ltd. Dr. Reddy's Laboratories Limited Gilead Sciences Hetero Labs Hikma… |
| Status | Recruiting |
| Study type | Observational |
| Conditions | HIV Infections, Hepatitis B |
| Enrollment | 24,258 |
| Start date | Jan 1, 1989 |
| Primary completion | Jan 1, 2099 |
| Completion | Jan 1, 2099 |
| First posted | Nov 29, 2006 |
| Last update posted | Apr 1, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: